ResMed (RMD) 10-K Summary — Year Ended Jun 30, 2024
ResMed Inc. filed its annual report. The filing provides financial metrics indicating revenue growth and strong operating cash flow, while the business overview and risk factor sections only contain page references.
Key takeaway
Year ended Jun 30, 2024 · FY2025 10-K
ResMed Inc. filed its annual report. The filing provides financial metrics indicating revenue growth and strong operating cash flow, while the business overview and risk factor sections only contain page references.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$4.7B
Revenue reported for the fiscal year.
Operating income
$1.3B
Income from operations reported for the year.
Net income
$1B
Net income reported for the year.
Operating cash flow
$1.4B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2021 | $3.2B | n/a |
| Jun 30, 2022 | $3.6B | +11.9% |
| Jun 30, 2023 | $4.2B | +18.0% |
| Jun 30, 2024 | $4.7B | +10.9% |
Business overview
The business overview section of the filing only lists page numbers and does not describe the company's products, markets, or operations. No other section in the supplied context provides a business description. Therefore, the company's business activities are not detailed in this filing.
Financial performance
Revenue increased over the reported periods, with the most recent year showing continued growth. Operating income and net income were reported at substantial levels. Operating cash flow was robust and exceeded net income.
Material risks
The risk factors section of the filing only contains a page reference and does not list any specific risks. No material risks are described in the supplied context. Therefore, no risk information is available from this filing.
Liquidity and capital
The company's liquidity comes from cash, cash equivalents, operating cash flow, and a revolving credit facility. Cash is used for research and development, sales and marketing, capital expenditures, acquisitions, dividends, and debt repayment. Future capital needs depend on revenue growth, reimbursement, and spending, and the company may seek external financing for inorganic growth.
What to watch
Monitor the company's discussion of supply chain disruptions and their impact on operating results in the next filing.